🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9,250 results for “IO” Clear

  1. maribavir, Maribavir, LIVTENCITY 200 mg film-coated tablets., Maribavir

    Takeda

    Cytomegalovirus (CMV) infection in children and adolescents who have received a hematopoietic stem cell transplant (HSCT) or a solid organ transplant (SOT)

    phase 3 small molecule active

    1 trial

  2. mavrilimumab

    Kiniksa Pharmaceuticals International, plc

    COVID

    phase 3 small molecule completed

    1 trial

  3. methadone

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 3 small molecule completed

    1 trial

  4. mifepristone

    CORCEPT THERAPEUTICS INC

    Psychotic Depression

    phase 3 small molecule terminated

    1 trial

  5. mipomersen

    IONIS PHARMACEUTICALS INC

    Lipid Metabolism, Inborn Errors

    phase 3 small molecule completed

    2 trials

  6. mipomersen sodium

    IONIS PHARMACEUTICALS INC

    Heterozygous Familial Hypercholesterolemia

    phase 3 small molecule completed

    1 trial

  7. mipomersen sodium

    IONIS PHARMACEUTICALS INC

    Lipid Metabolism, Inborn Errors

    phase 3 small molecule completed

    2 trials

  8. misoprostol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Labor Induction

    phase 3 small molecule completed

    1 trial

  9. mosapride citrate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Constipation

    phase 3 small molecule completed

    1 trial

  10. naltrexone implant

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 3 small molecule completed

    1 trial

  11. neratinib

    PUMA BIOTECHNOLOGY, INC.

    HER2+ Metastatic Breast Cancer (MBC)

    phase 3 small molecule completed

    1 trial

  12. nicotine transdermal system

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 3 small molecule completed

    2 trials

  13. nomacopan (rVA576)

    Akari Therapeutics Plc

    Thrombotic Microangiopathies

    phase 3 small molecule terminated

    1 trial

  14. normal saline solution for infusion, Ociperlimab, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Tislelizumab, Ociperlimab

    BeiGene

    Locally advanced, unresectable, or metastatic non small cell lung cancer

    phase 3 small molecule active

    1 trial

  15. nutritional supplement

    Abbott Australasia Pty Ltd

    Children

    phase 3 other completed

    1 trial

  16. olmesartan alone or in combination with hydrochlorothiazide

    Pfizer

    Essential Hypertension

    phase 3 small molecule completed

    1 trial

  17. oral estradiol 1.0 mg

    TherapeuticsMD

    Menopause

    phase 3 small molecule completed

    1 trial

  18. pad-gauze with tranexamic acid (Hemostopan™)

    Sionna Therapeutics

    Bleeding

    phase 3 other active

    1 trial

  19. pantoprazole 20 mg (drug)

    Takeda

    Chronic Use of Acid Suppressive Medication

    phase 3 small molecule active

    1 trial

  20. pegaptanib sodium

    Pfizer

    Macular Degeneration

    phase 3 small molecule completed

    1 trial

  21. pegcyte

    Biotech Pharmaceutical Co.,

    Breast Cancer Female

    phase 3 small molecule completed

    1 trial

  22. piclidenoson

    Can-Fite BioPharma

    Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  23. pioglitazone

    Hoffmann-La Roche

    Diabetes Mellitus Type 2

    phase 3 small molecule completed

    1 trial

  24. pioglitazone

    Takeda

    Stroke

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources